endometrial%20cancer
ENDOMETRIAL CANCER

Endometrial cancer is also known as uterine cancer, cancer of the corpus uteri, uterine corpus cancer, endometrical carcinoma.

It is the 6th most common malignancy worldwide.

Management of endometrial cancer should be divided based on risk, disease stage & patient's desire for fertility.

Endometrial%20cancer Signs and Symptoms

Definition

  • Also known as uterine cancer, cancer of the corpus uteri, uterine corpus cancer, endometrial carcinoma
  • The 6th most common malignancy worldwide
  • The most common gynecologic cancer in developed countries; 2nd most common in developing countries
  • More commonly presents in individuals >50 years of age
  • Usually diagnosed in its early stages and still localized, with high survival rates

Etiology

  • Endometrial intraepithelial neoplasia (atypical endometrial hyperplasia) is the precursor lesion to endometrial cancer according to the 1994 World Health Organization (WHO) and International Endometrial Collaborative Group schemas
  • Papillary serous carcinoma accounts for 10% of cases, but comes with high mortality rates (40%)
  • Clear cell histologic type is rare (3%) but with poor prognosis

Risk Factors

  • Age ≥55 years
  • Excess estrogen (eg estrogen therapy, estrogen-producing tumors, early menarche, late menopause)
  • Obesity; high body mass index
  • Metabolic syndrome (eg hypertension, DM)
  • Nulliparity, infertility
  • Polycystic ovarian syndrome (PCOS)
  • Genetic mutation (eg hereditary non-polyposis colorectal cancer/Lynch syndrome)
  • Family history of endometrial cancer
  • Smoking

Prognostic Factors

  • Age
  • International Federation of Gynecology and Obstetrics (FIGO) stage
  • Depth of myometrial invasion
  • Tumor differentiation grade
  • Tumor type
  • Lymphovascular space invasion
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.